DC Influenza Surveillance Data
DC Health produces regular influenza surveillance reports during the influenza season. Please email [email protected] if you would like to be included on the report mailing list.
►2018 - 2019 reports by MMWR week:
- MMWR Week 40 (September 30, 2018 - October 6, 2018)
- MMWR Week 41 (October 7, 2018 - October 13, 2018)
- MMWR Week 42 (October 14, 2018 - October 20, 2018)
- MMWR Week 43 (October 21, 2018 - October 27, 2018)
- MMWR Week 44 (October 28, 2018 - November 3, 2018)
- MMWR Week 45 (November 4, 2018 - November 10, 2018)
- MMWR Week 46 (November 11, 2018- November 17, 2018)
- MMWR Week 47 (November 18, 2018 - November 24, 2018)
- MMWR Week 48 (November 25, 2018 - December 1, 2018)
- MMWR Week 49 (December 2, 2018 - December 8, 2018)
- MMWR Week 50 (December 9, 2018 - December 15, 2018)
- MMWR Week 51 (December 16, 2018 - December 22, 2018)
- MMWR Week 52 (December 23, 3018 - December 29, 2018)
- MMWR Week 1 (December 30, 2018 - January 5, 2019)
- MMWR Week 2 (January 6, 2019 - January 12, 2019)
- MMWR Week 3 (January 13, 2019 - January 19, 2019)
- MMWR Week 4 (January 20, 2019 - January 26, 2019)
- MMWR Week 5 (January 27, 2019 - February 2, 2019)
- MMWR Week 6 (February 3, 2019 - February 9, 2019)
- MMWR Week 7 (February 10, 2019 - February 16, 2019)
- MMWR Week 8 (February 17, 2019 - February 23, 2019)
- MMWR Week 9 (February 24, 2019 - March 2, 2019)
- MMWR Week 10 (March 3, 2019 - March 9, 2019)
- MMWR Week 11 (March 10, 2019 - March 16, 2019)
- MMWR Week 12
- MMWR Week 13
- MMWR Week 14
- MMWR Week 15
- MMWR Week 16
- MMWR Week 17
- MMWR Week 18
- MMWR Week 19
- MMWR Week 20
- Archived District MMWR Reports (oldest season: 2011-2012)
Surveillance and Reporting
Routine surveillance in DC commenced on September 30, 2018 and will continue until May 18, 2019. The Division of Epidemiology- Disease Surveillance and Investigation (DE-DSI) will continue to collect data on aggregate confirmed influenza cases and influenza-like-illness (ILI) on a weekly basis. To find out more information about the 2018-2019 season recommendations, please review our Health Notice from October 10, 2018.
Healthcare providers that would like to help strengthen influenza-like-illness surveillance in the District can enroll to be part of the CDC’s ILINet surveillance program. For more information on what ILINet is, who is eligible, and why you should participate, take a look at this fact sheet.
Please contact us at [email protected] to learn more or if you would like to enroll.
Virologic Surveillance and Influenza Specimen Submission by DC Clinical Laboratories
For larger health care practices and facilities, regular submission of a subset of your collected influenza specimens to the DC Public Health Laboratory (PHL) for virologic surveillance is strongly encouraged. Virologic surveillance is an essential part of the DC and national influenza surveillance system, allowing for:
- Increased awareness of seasonal influenza burden and determination of strain prevalence
- Early detection of novel viruses or events
- Annual vaccine strain selection
- Antiviral resistance monitoring
Please contact us at [email protected] to learn more or to coordinate specimen submission.
In the District, influenza is reportable for the following cases:
Influenza associated pediatric deaths (<18 years old)
Novel Influenza A infection
Any influenza outbreak
Reporting of influenza associated hospitalizations or non-pediatric deaths is strongly encouraged, but not required
No other individual cases of influenza are reportable to DC Health. Cases should be reported to DE-DSI online by submitting a Notifiable Disease and Condition Case Report Form using DC Reporting and Surveillance Center (DCRC). Please contact us at [email protected] with any questions about influenza reporting.
Influenza-Associated Pediatric Death Case Definition
An influenza associated pediatric death is defined as a death resulting from a clinically compatible illness that was confirmed to be influenza by an appropriate laboratory or rapid diagnostic test. There should be no period of complete recovery between the illness and death. Any such death in persons <18 years is required to be reported. Laboratory testing for influenza virus infection may be done on pre- or post-mortem clinical specimens.
A death should not be reported if:
- There is no laboratory confirmation of influenza virus infection.
- The influenza illness is followed by full recovery to baseline health status prior to death.
- After review and consultation there is an alternative agreed upon cause of death.
Novel Influenza A Infection Case Definition
Novel influenza A infection is defined as a human case of infection with an influenza A virus subtype that is different from currently circulating human influenza H1 and H3 viruses. Novel subtypes include, but are not limited to, H2, H5, H7 and H9 subtypes. Influenza H1 and H3 subtypes originating from a non-human species or from genetic reassortment between animal and human viruses are also novel subtypes.
Influenza Outbreak Definition
An outbreak is defined as an occurrence of disease greater than would otherwise be expected at a particular time and place. The definition of an influenza outbreak depends on the setting of the outbreak. Listed below are examples of when DC Health should be consulted:
- Outbreaks in institutions such as long-term facilities, prisons, sleepover camps etc. is defined as one laboratory-confirmed influenza positive case in the setting of a cluster (≥2 cases) of influenza-like illness(ILI)* within a 72-hour period.
- Outbreaks in schools should be considered if students or staff of the same classroom are experiencing influenza-like illness or other respiratory symptoms.
Defining an outbreak should be done in consultation with the epidemiologists at DC Health. Please contact the influenza team at [email protected] for further guidance about influenza outbreaks.